Australian players can enjoy colourful slots, immersive reels, and interactive bonuses while spinning at King Johnnie, creating a fun online adventure.

Casino Mate Australia provides fast spins, rewarding promotions, and engaging reels, giving Australian punters a lively and dynamic gaming experience.

Spinrise Casino delivers vibrant gameplay, interactive features, and exciting rewards, allowing Australian audiences to enjoy a smooth and thrilling session at Spinrise Casino.

Wild Fortune Casino brings immersive slots, engaging reels, and rewarding bonuses, giving Australian players an exciting and lively online experience on Wild Fortune Casino.

Explore colourful reels, claim interactive promotions, and enjoy smooth gameplay while playing at King Billy, creating a thrilling adventure for Australian audiences.

Ricky Casino Australia offers immersive reels, fast spins, and rewarding bonuses, letting Australian players enjoy a fun and engaging online session at Ricky Casino Australia.

Spin exciting slots, claim interactive rewards, and explore immersive gameplay while playing at RipperCasino, giving Australian punters a lively experience.

Joe Fortune Casino provides engaging reels, vibrant slots, and rewarding promotions, allowing Australian players to enjoy smooth gameplay and a dynamic adventure on Joe Fortune Casino.

Entero Healthcare Solutions Limited, one of India’s leading and fastest-growing healthcare product distribution platform, has launched its ‘HealthEdge’ programme for retail chemists. In line with this, Entero has acquired the tech-driven Aayu Chemist app and Medcords platform from Medcords Healthcare Solutions. This strategic move accelerates the digital transformation of retail chemists, equipping them with cutting-edge tools to enhance business efficiency, profitability, customer engagement and better purchase experience.

With a current network of 86,000+ retail chemists, Entero aims to deepen its chemist engagement. The acquisition of Aayu Chemist and Medcords aligns with Entero’s commitment to integrating technology and healthcare distribution to drive sustained business growth.

Commenting on this development, Mr. Prabhat Agrawal, MD & CEO of Entero Healthcare, said, “The HealthEdge programme aligns perfectly with our vision to be a growth catalyst for retail chemists. Through this digital enablement, we empower chemists to stay ahead of the curve, ensuring their businesses are resilient and primed for significant growth. Retail chemists are invited to become part of the ‘HealthEdge’ ecosystem, and together, we will shape a future where technology and healthcare distribution work hand-in-hand to unlock new levels of success.”

Shreyans, Co-Founder of Aayu Chemist by MedCords, added, “Quick commerce, with its focus on rapid delivery of everyday essentials, is impacting kirana and chemist shops in India by attracting customers seeking convenience, leading to a shift in consumer spending and potentially impacting the livelihoods of small business owners. Our journey with MedCords has always centred on empowering retail chemists, the backbone of India’s healthcare system. Partnering with Entero amplifies this mission, bringing our technology and expertise to a broader

Transformative Features and Benefits of the ‘HealthEdge’ Programme

  • Superfast Medicine Supply and Inventory Management – Increasing customer fill rate, Optimized logistics, ensuring seamless stock availability.
  • Transparent Expiry Management and Auto-Refill Systems – Reducing sales and inventory losses for chemists.
  • Exclusive Access to New Products and High-Margin Deals – Enhancing profitability.
  • Seamless Online Store Management – Personalized website and app, plus ABHA-enabled pharmacy recognition for a competitive edge.
  • Customer Retention Tools – Medicine reminders, loyalty programs, and digital payment solutions to foster stronger customer relationships.
  • Access to Healthcare Services – Offering doctor consultations and lab test bookings for a holistic customer experience.
  • Financial Support – Credit facilities to retail chemists under this initiative, providing financial flexibility and stability.
  • Integration with the Government’s Digital Health Incentive Scheme – Enhancing operational efficiency and incentives for participants.

Entero Healthcare has witnessed strong performance in Q3FY25 with 37% revenue growth and 322% PAT growth over previous year.

Entero Healthcare Solutions Limited (Entero) is one of India’s leading and fastest-growing healthcare products distribution platforms. Established in 2018, Entero has rapidly scaled to become a key player in the pharmaceutical supply chain with a customer base of 86,200+ retail pharmacies, 3200+ hospitals in 492 districts of India. With a network of 104 warehouses and last mile delivery infrastructure spread across the country, supply relationships with 2500+ healthcare product manufacturers Entero provides a PAN India, technology driven healthcare distribution platform. Driven by a proprietary technology platform, Entero enables seamless integration of data intelligence, demand generation, and fulfilment solutions. Entero’s commitment to operational excellence is supported by its experienced leadership team, a healthcare-focused investor base, and a relentless pursuit of innovation. By combining a customer-centric approach with advanced logistics infrastructure, Entero is reshaping India’s fragmented pharmaceutical distribution landscape, ensuring accessibility, affordability, and efficiency in healthcare delivery.

About the author: IE&M Team
Picture of IE&M Team
Indian Economy & Market is an Indian media and information platform producing data-backed news and analysis on all the vital elements at the intersection of the economy, stock markets, mutual fund, insurance, commodities, currency, technology, startups and business.

More articles by the author

Table of Contents